Order Article Reprints

Oliva EN, Platzbecker U, Garcia-Manero G, Mufti GJ, Santini V, Sekeres MA, Komrokji RS, Shetty JK, Tang D, Guo S, et al. Health-Related Quality of Life Outcomes in Patients with Myelodysplastic Syndromes with Ring Sideroblasts Treated with Luspatercept in the MEDALIST Phase 3 Trial. Journal of Clinical Medicine. 2022; 11(1):27. https://doi.org/10.3390/jcm11010027

Oliva, Esther Natalie, Uwe Platzbecker, Guillermo Garcia-Manero, Ghulam J. Mufti, Valeria Santini, Mikkael A. Sekeres, Rami S. Komrokji, Jeevan K. Shetty, Derek Tang, Shien Guo, and et al. 2022. "Health-Related Quality of Life Outcomes in Patients with Myelodysplastic Syndromes with Ring Sideroblasts Treated with Luspatercept in the MEDALIST Phase 3 Trial" Journal of Clinical Medicine 11, no. 1: 27. https://doi.org/10.3390/jcm11010027

Oliva, E. N., Platzbecker, U., Garcia-Manero, G., Mufti, G. J., Santini, V., Sekeres, M. A., Komrokji, R. S., Shetty, J. K., Tang, D., Guo, S., Liao, W., Zhang, G., Ha, X., Ito, R., Lord-Bessen, J., Backstrom, J. T., & Fenaux, P. (2022). Health-Related Quality of Life Outcomes in Patients with Myelodysplastic Syndromes with Ring Sideroblasts Treated with Luspatercept in the MEDALIST Phase 3 Trial. Journal of Clinical Medicine, 11(1), 27. https://doi.org/10.3390/jcm11010027